Sign in Create account

Veerhealth Care Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 511523
₹49.58
▲ 0.19 (0.38%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
51/100
Moderate
Valuation
44/100
Fairly Valued
Momentum
54/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹99 Cr
PE (TTM)
65.2
Industry median 36.1 (152 companies)
Price to Book
4.3
PEG (TTM)
0.3
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
151.7
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
408.33%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
109.15%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
177.23%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
409.13%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
455.76%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.37
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.20
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
5.62
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
4.92%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
6.86%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
5.73%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
1.23%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
5.41%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
2.38%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.20)
  • No Return on equity is 15% or more (2.4%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.4%
Low 49.1000 · High 50.3700
1W return
-1.0%
Low 48.0000 · High 50.7000
1M return
-0.6%
Low 47.9900 · High 52.0000
52W return
151.7%
Low 43.5000 · High 52.0000
Lifetime High ₹50.9400 (Sept. 15, 2026)
Lifetime Low ₹0.2400 (March 5, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish4
Bearish2
5D
49.6
10D
49.7
20D
49.1
50D
43.4
100D
36.3
200D
26.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

49.68
Pivot
First resistance50.27
Second resistance50.95
Third resistance51.54
First support49.00
Second support48.41
Third support47.73
Day RSI62.3
Day MFI52.7
Day MACD1.49
Day MACD signal2.16

Beta

1M0.06
3M0.14
1Y0.14
3Y-0.03

Price change analysis

↓ -0.6%
Over 1 Month
LowHigh
47.9952.00
↑ 151.7%
Over 3 Months
LowHigh
43.5052.00
↑ 151.7%
Over 6 Months
LowHigh
43.5052.00
↑ 151.7%
Over 1 Year
LowHigh
43.5052.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 65.2 (own history: 25.9–525.3)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹25 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹0.6100

Ranks #140 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter31.91%

Largest holders

NameCategoryShares %Shares
YOGESH MAHASUKLAL SHAHPromoter12.2300%2445070
YOGESH SHAH HUFPromoter4.2100%841114
KRUPA HARSH JAINPromoter3.9500%790062
RUCHI YOGESH SHAHPromoter3.3300%665124
SHRUTI AKASH SHAHPromoter3.2900%657800

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 31.50% to 31.91% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 491 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
13 Aug 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Sell 9,985 46.9000 BSE
13 Aug 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Buy 108,343 46.5700 BSE
27 Jul 2026 SHILPABEN ALPESHBHAI SHAH Bulk Sell 106,987 42.2000 BSE
27 Jul 2026 BHAVIK RAJAN KAPADIA Bulk Buy 236,000 42.2000 BSE
8 Jul 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Sell 150,632 37.6200 BSE
8 Jul 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Buy 212,523 37.8700 BSE
29 Jun 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Buy 47,151 31.6700 BSE
29 Jun 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Sell 109,128 32.1600 BSE
17 Jun 2026 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Buy 29,972 27.3400 BSE
17 Jun 2026 ALPA SUNIL CHHEDA Bulk Buy 200,000 27.7900 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from NIYATI INDUSTRIES LTD. to Veerhealth Care Limited

All corporate actions →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Company Update Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
28 Sep 2026 Insider Trading / SAST Veerhealth Care Ltd - 511523 - Closure of Trading Window
25 Sep 2026 AGM/EGM Veerhealth Care Ltd - 511523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
11 Sep 2026 Company Update Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
9 Sep 2026 Company Update Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.20)
  • Strong revenue growth YoY (455.8%)

Weaknesses

  • Low Return on Equity (2.4%)
  • Thin net profit margin (4.9%)

Opportunities

  • PEG below 1 (0.34) -- earnings growth outpacing its own valuation

Threats

  • PE above 35 (65.2) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Veerhealth Care Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.